This educational program consists of three presentations on residual CVD risk with a focus on triglycerides and triglyceride-rich lipoproteins,

This course consists of the following:

• The residual risk challenge in CVD: How important are triglycerides? - Prof. Ulf Landmesser, MD – Berlin, Germany
• Non-LDL-c parameters in CV risk management and guidelines - Prof. Kausik Ray, MD – London, UK
• Lessons from REDUCE-IT - Prof. Deepak Bhatt, MD – Boston, MA, USA

After watching these three videos, the learner should be able to:

• Name major drivers of CVD risk
• Describe the effect of genetically lower triglyceride vs. lower LDL-c on CHD
• Recall what is in the ESC 2019 guidelines on lipid analyses for CVD risk estimation
• Discuss findings with statin therapy in patients with high TG and TRL-c levels
• List approaches to lower CVD risk in patients with atherogenic dyslipidemia
• Describe details and findings of REDUCE-IT

Expert faculty

• Prof. Ulf Landmesser, MD, cardiologist, Charité-Universitätsmedizin Berlin, Germany.
• Prof. Kausik Ray, MD, is a cardiologist, and Professor of Public Health/Honorary Consultant Cardiologist at Imperial College London, United Kingdom.
• Prof. Deepak L. Bhatt, MD, MPH is Executive Director of Interventional Cardiovascular Programs and Professor at Harvard Medical School, Boston, MA, USA.

Target audience

This educational activity is designed for cardiologists in secondary care and other healthcare professionals with an interest in lipoproteins and lipoprotein-rich particles.

CME accreditation

This online course is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit.

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Amarin.